Peter Fitzgerald
Dunedin, OTA 9054, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2.
Journal: Journal of cancer research and clinical oncology
Published: February 22, 2022
Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years.
Journal: American journal of obstetrics and gynecology
Published: April 08, 2021
Cytopathological review of cervical pathology: Impact for women and follow-up results.
Journal: The Australian & New Zealand journal of obstetrics & gynaecology
Published: October 27, 2019
Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.
Journal: American journal of obstetrics and gynecology
Published: September 26, 2019
The impact of primary HPV screening on the incidence of cervical cancer in New Zealand.
Journal: Journal of the American Society of Cytopathology
Published: January 29, 2019
Changes in human papillomavirus genotypes associated with cervical intraepithelial neoplasia grade 2 lesions in a cohort of young women (2013-2016).
Journal: Papillomavirus research (Amsterdam, Netherlands)
Published: May 23, 2018
Observational Management of CIN 2 in Young Women: A Prospective Multicenter Trial.
Journal: Journal of lower genital tract disease
Published: August 03, 2016
The proposed change to primary HPV screening in New Zealand: reasons for caution.
Journal: The New Zealand medical journal
Published: March 24, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026